Hot Themes

Montag, 22. Mai 2017

Lithium-Gigant Albemarle: Starke Fundamentaldaten und glänzende Aussichten

Die Outperformance der Albemarle-Aktie in den letzten Monaten spricht für sich..

Albemarle (ALB) Scales New 52-Week High on Bright Prospects

Shares of chemicals maker Albemarle ALB scaled a fresh 52-week high of $112.82 yesterday, before pulling back to close the day at $112.05.

Albemarle has a market cap of roughly $12.4 billion and average volume of shares traded in the last three months is around 1,053.7K. The company has an expected long-term EPS growth of around 14.5%.

Albemarle has significantly outperformed the Zacks categorized Chemicals-Diversified industry over a year, partly reflecting its forecast-topping earnings performance and its strategic growth initiatives. The company’s shares have gained around 47.1% over this period, compared with roughly 17.5% gain recorded by the industry.

Driving Factors

Albemarle's adjusted earnings of $1.05 per share for first-quarter 2017 topped the Zacks Consensus Estimate of 95 cents. Revenues of $722.1 million also beat the Zacks Consensus Estimate of $678.7 million..

Keine Kommentare:

Kommentar veröffentlichen